Clinical 16S Microbiome Profiling
Technical Overview
CAP/CLIA validated service for bacterial community analysis with flexible configurations for read counts and sequencing depths. Uses Zymo Quick-16S Plus NGS Library Prep Kit (V4) targeting the bacterial V4 region of 16S rRNA.
Test Information:
- Deliverables: FASTQ files (for CAP/CLIA), taxonomy profiles in text format down to genus level (for Research/RUO using custom pipeline)
- Platform: Illumina MiSeq (2x176 reads configuration)
- Sample Types: Stool and Vaginal Swab
- Turnaround Time: 14 business days
- Minimum Batch Size: 1 sample (may increase TAT to 4 weeks), optimal batch size is 192 samples
- Performance Criteria: >20,000 reads/sample after filtering is applied
About the Service
Clinical 16S Microbiome Profiling by Eurofins Genomics: a CAP/CLIA-validated solution for comprehensive bacterial community analysis. This advanced service leverages high-throughput sequencing technology to provide accurate, reproducible, and high-resolution profiling of complex microbial populations.
Cutting-Edge 16S Sequencing for Clinical and Research Applications
Our 16S microbiome profiling service is designed to meet the highest clinical standards, providing researchers and healthcare professionals with precise insights into bacterial communities. Using the Zymo 16S V4 quick kit, this service targets specific regions of the bacterial 16S gene, ensuring robust and taxonomically informative sequencing data.
Specifications
-
CAP/CLIA-Validated – Ensures compliance with rigorous clinical quality standards.
-
Flexible Configurations – Customizable read counts and sequencing depths to meet project-specific requirements.
-
Targeted 16S V4 Sequencing – High-resolution bacterial identification and community composition analysis.
-
Optimized Workflow – Rapid turnaround times and streamlined data analysis for efficient microbiome research.
Applications of Clinical 16S Microbiome Profiling
Our service is designed to support a wide range of clinical and research applications, including:
-
Bacterial Community Analysis – Characterization of microbiome diversity and composition in clinical and environmental samples.
-
Microbiome Research – Investigation of microbiome-associated health and disease states, including gut, oral, skin, and respiratory microbiomes.
-
Microbiome Composition Assessment – Identification of microbial shifts associated with infections, dysbiosis, or therapeutic interventions.
Benefits of Eurofins Genomics’ 16S Microbiome Profiling
-
Regulatory Compliance – CAP/CLIA validation ensures data integrity and clinical applicability.
-
High Sensitivity & Accuracy – Targeted 16S sequencing enables precise taxonomic classification of bacterial communities.
-
Scalable Solutions – Tailored sequencing depths accommodate studies of various sizes, from small cohorts to large-scale clinical research.
-
Expert Support – Comprehensive bioinformatics and data interpretation services to help you translate sequencing data into actionable insights.
With the launch of our Clinical 16S Microbiome Profiling service, Eurofins Genomics continues to expand its portfolio of cutting-edge sequencing solutions for microbiome research and clinical diagnostics.
Contact us today to learn how our 16S microbiome profiling service can enhance your research and clinical applications.
Get Started
Contact us today to learn more about our Clinical Whole Genome Sequencing services and how they can support your research and clinical applications.
Eurofins Clinical Enterprise and Eurofins Genomics
Eurofins Clinical Enterprise (CE) is the clinical arm of Eurofins Genomics. CE processes all clinical and non-clinical NGS samples for Eurofins Genomics in the United States. Samples, quotes, and results are managed through the CE group.